Broadfin Capital, LLC Buys Allergan PLC, Biohaven Pharmaceutical Holding Co, Eiger BioPharmaceuticals Inc, Sells Iovance Biotherapeutics Inc, Catalyst Pharmaceuticals Inc, Adamas Pharmaceuticals Inc

New York, NY, based Investment company Broadfin Capital, LLC (Current Portfolio) buys Allergan PLC, Biohaven Pharmaceutical Holding Co, Eiger BioPharmaceuticals Inc, Sientra Inc, Heron Therapeutics Inc, sells Iovance Biotherapeutics Inc, Catalyst Pharmaceuticals Inc, Adamas Pharmaceuticals Inc, Aclaris Therapeutics Inc, Mirati Therapeutics Inc during the 3-months ended 2019Q2, according to the most recent filings of the investment company, Broadfin Capital, LLC. As of 2019Q2, Broadfin Capital, LLC owns 38 stocks with a total value of $453 million. These are the details of the buys and sells.

For the details of Broadfin Capital, LLC's stock buys and sells, go to https://www.gurufocus.com/guru/broadfin+capital%2C+llc/current-portfolio/portfolio

These are the top 5 holdings of Broadfin Capital, LLC
  1. Iovance Biotherapeutics Inc (IOVA) - 1,559,299 shares, 8.43% of the total portfolio. Shares reduced by 63.97%
  2. Aratana Therapeutics Inc (PETX) - 7,258,135 shares, 8.26% of the total portfolio.
  3. Nevro Corp (NVRO) - 488,265 shares, 6.98% of the total portfolio. Shares reduced by 21.58%
  4. Biohaven Pharmaceutical Holding Co Ltd (BHVN) - 676,879 shares, 6.54% of the total portfolio. Shares added by 174.15%
  5. Retrophin Inc (RTRX) - 1,053,314 shares, 4.67% of the total portfolio. Shares added by 3.66%
New Purchase: Allergan PLC (AGN)

Broadfin Capital, LLC initiated holding in Allergan PLC. The purchase prices were between $115.73 and $167.43, with an estimated average price of $138.45. The stock is now traded at around $157.92. The impact to a portfolio due to this purchase was 4.24%. The holding were 114,804 shares as of .

New Purchase: Sientra Inc (SIEN)

Broadfin Capital, LLC initiated holding in Sientra Inc. The purchase prices were between $5.43 and $9.06, with an estimated average price of $7.2. The stock is now traded at around $6.84. The impact to a portfolio due to this purchase was 1.9%. The holding were 1,400,000 shares as of .

New Purchase: Amarin Corp PLC (AMRN)

Broadfin Capital, LLC initiated holding in Amarin Corp PLC. The purchase prices were between $16.27 and $20.51, with an estimated average price of $18.3. The stock is now traded at around $14.91. The impact to a portfolio due to this purchase was 1.24%. The holding were 291,000 shares as of .

New Purchase: Wright Medical Group NV (WMGI)

Broadfin Capital, LLC initiated holding in Wright Medical Group NV. The purchase prices were between $27.8 and $32.5, with an estimated average price of $30.47. The stock is now traded at around $21.21. The impact to a portfolio due to this purchase was 0.83%. The holding were 126,400 shares as of .

Added: Biohaven Pharmaceutical Holding Co Ltd (BHVN)

Broadfin Capital, LLC added to a holding in Biohaven Pharmaceutical Holding Co Ltd by 174.15%. The purchase prices were between $39.79 and $67.01, with an estimated average price of $56.51. The stock is now traded at around $38.68. The impact to a portfolio due to this purchase was 4.15%. The holding were 676,879 shares as of .

Added: Eiger BioPharmaceuticals Inc (EIGR)

Broadfin Capital, LLC added to a holding in Eiger BioPharmaceuticals Inc by 756.77%. The purchase prices were between $9.54 and $14.96, with an estimated average price of $11.53. The stock is now traded at around $10.12. The impact to a portfolio due to this purchase was 3.42%. The holding were 1,656,137 shares as of .

Added: Heron Therapeutics Inc (HRTX)

Broadfin Capital, LLC added to a holding in Heron Therapeutics Inc by 216.35%. The purchase prices were between $16.93 and $26.22, with an estimated average price of $20. The stock is now traded at around $16.94. The impact to a portfolio due to this purchase was 1.85%. The holding were 657,998 shares as of .

Sold Out: Aclaris Therapeutics Inc (ACRS)

Broadfin Capital, LLC sold out a holding in Aclaris Therapeutics Inc. The sale prices were between $2.13 and $7.06, with an estimated average price of $5.45.

Sold Out: Mirati Therapeutics Inc (MRTX)

Broadfin Capital, LLC sold out a holding in Mirati Therapeutics Inc. The sale prices were between $59.49 and $104.71, with an estimated average price of $77.61.

Sold Out: Intersect ENT Inc (XENT)

Broadfin Capital, LLC sold out a holding in Intersect ENT Inc. The sale prices were between $22.43 and $33.65, with an estimated average price of $26.98.

Sold Out: Sierra Oncology Inc (SRRA)

Broadfin Capital, LLC sold out a holding in Sierra Oncology Inc. The sale prices were between $0.56 and $1.7, with an estimated average price of $1.22.

Sold Out: Integra Lifesciences Holdings Corp (IART)

Broadfin Capital, LLC sold out a holding in Integra Lifesciences Holdings Corp. The sale prices were between $46.45 and $55.85, with an estimated average price of $51.45.

Sold Out: LivaNova PLC (LIVN)

Broadfin Capital, LLC sold out a holding in LivaNova PLC. The sale prices were between $66.45 and $97.36, with an estimated average price of $73.07.

Reduced: Iovance Biotherapeutics Inc (IOVA)

Broadfin Capital, LLC reduced to a holding in Iovance Biotherapeutics Inc by 63.97%. The sale prices were between $9.78 and $24.52, with an estimated average price of $15.03. The stock is now traded at around $20.76. The impact to a portfolio due to this sale was -5.44%. Broadfin Capital, LLC still held 1,559,299 shares as of .

Reduced: Catalyst Pharmaceuticals Inc (CPRX)

Broadfin Capital, LLC reduced to a holding in Catalyst Pharmaceuticals Inc by 52.79%. The sale prices were between $2.7 and $6.11, with an estimated average price of $4.32. The stock is now traded at around $5.58. The impact to a portfolio due to this sale was -3.26%. Broadfin Capital, LLC still held 2,765,070 shares as of .

Reduced: Adamas Pharmaceuticals Inc (ADMS)

Broadfin Capital, LLC reduced to a holding in Adamas Pharmaceuticals Inc by 82.14%. The sale prices were between $4.29 and $7.24, with an estimated average price of $5.75. The stock is now traded at around $6.65. The impact to a portfolio due to this sale was -2.98%. Broadfin Capital, LLC still held 441,088 shares as of .

Reduced: Nevro Corp (NVRO)

Broadfin Capital, LLC reduced to a holding in Nevro Corp by 21.58%. The sale prices were between $58.04 and $66.99, with an estimated average price of $62.27. The stock is now traded at around $81.65. The impact to a portfolio due to this sale was -1.73%. Broadfin Capital, LLC still held 488,265 shares as of .

Reduced: La Jolla Pharmaceutical Co (LJPC)

Broadfin Capital, LLC reduced to a holding in La Jolla Pharmaceutical Co by 55.3%. The sale prices were between $5.32 and $12.86, with an estimated average price of $7.5. The stock is now traded at around $9.79. The impact to a portfolio due to this sale was -1.47%. Broadfin Capital, LLC still held 891,760 shares as of .

Reduced: NanoString Technologies Inc (NSTG)

Broadfin Capital, LLC reduced to a holding in NanoString Technologies Inc by 78.98%. The sale prices were between $23.35 and $30.35, with an estimated average price of $26.46. The stock is now traded at around $27.23. The impact to a portfolio due to this sale was -1.39%. Broadfin Capital, LLC still held 74,786 shares as of .



Here is the complete portfolio of Broadfin Capital, LLC. Also check out:

1. Broadfin Capital, LLC's Undervalued Stocks
2. Broadfin Capital, LLC's Top Growth Companies, and
3. Broadfin Capital, LLC's High Yield stocks
4. Stocks that Broadfin Capital, LLC keeps buying